Accuracy of CGM in the ICU, Compared to Standard of Care

University of British Columbia20 enrolled

Overview

To determine the performance of the Dexcom CGM device in comparison to arterial glucose samples.

The performance of the Dexcom continuous glucose sensor will be compared with the current standard of care which is arterial glucose samples analyzed on a glucose meter. Subjects will be ICU patients receiving intravenous insulin infusions.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diabetes

Interventions

Continuous Glucose SensorDEVICE

Continuous glucose sensor results will be compared with arterial glucose samples

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * minimum age 18 years * anticipated to be on an insulin infusion for 3-7 consecutive days * 10 of these subjects will be on vasopressors who will be receiving large volume fluid resuscitation Exclusion Criteria: * subjects not on insulin infusion

Locations (1)

Vancouver General Hospital

Vancouver, British Columbia, Canada

RECRUITING

Outcomes

Primary Outcomes

Continous Glucose Sensor values (CGM)

CGM will be compared with arterial glucose values

Time frame: 3 to 7 consecutive days

Secondary Outcomes

Vasopressor Use

10 of the 20 subjects will be on vasopressors and large volume fluid resuscitation

Time frame: 3 to 7 consecutive days

Central Contacts

David M Thompson, MD

CONTACT

604 875 5996 david.thompson@vch.ca

Barbara J Allan, MHA

CONTACT

604 875 5997 barbara.allan@vch.ca

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.